retatrutide peptide pen 40mg Research UK Retatrutide - “Triple G” |

Yes, these drugs were originally developed for type 2 diabetes but are now widely used for weight management because they reliably reduce appetite and induce significant weight loss

Retatrutide (also referred to as LY3437943) is an investigational triple receptor agonist that simultaneously activates glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors

However, two considerations matter when stopping: 1

Final Thoughts Menopause does not have to mean losing control of your body

Broader medical aesthetics courses offer essential foundations in anatomy, skin science, and safety - tools that are increasingly vital as the demand for semaglutide-related interventions grows

Related reading on PlexusDx: What Is GLP-1?, GLP-1 Receptor Agonist, GLP-1 Drugs, GLP-1 Hormone